FAIR for AYA Stamps 2021

Laureates 2021

Roche:

TAPISTRY (Phase II): ‘Tumor-agnostic precision immuno-oncology and somatic targeting rational for you (TAPISTRY) phase II platform trial’

ELI LILLY/LOXO ONCOLOGY:

LIBRETTO-001 (Phase I –II): ‘A Phase 1/2 Study of Oral LOXO-292 in Patients with Advanced Solid Tumors, Including RET Fusion-Positive Solid Tumors, Medullary Thyroid Cancer, and Other Tumors with RET Activation (LIBRETTO-001)’

ELI LILLY AND COMPANY:

LIBRETTO-531 (Phase III): ‘A Multicenter, Randomized, Open-label, Phase 3 Trial Comparing Selpercatinib to Physicians Choice of Cabozantinib or Vandetanib in Patients with Progressive, Advanced, Kinase Inhibitor Naïve, RET-Mutant Medullary Thyroid Cancer (LIBRETTO-531)’



For more information, please contact contact@accelerate-platform.org
You can tweet using #ACCELERATEplatform